基于MRI的前列腺PI-RADS 4分外周带病灶中不同临床显著前列腺癌检出率分析
该回顾性研究纳入206例外周带PI-RADS 4分患者,比较DWI 4与DWI 3/DCE+病灶的csPCa检出率,并以TB+SB为参考标准分析TB或SB的诊断效能,发现DWI 4病灶csPCa检出率高于DWI 3/DCE+,TB在DWI 3/DCE+患者中诊断性能好。
要点
- 外周带PI-RADS 4分中,DWI 4病灶csPCa检出率高于DWI 3/DCE+。
- TB+SB或SB下两组检出率差异显著,TB下差异不显著。
- DWI 3/DCE+且PSA 4-10 ng/mL患者,TB阴性预测值高。
核心结论
- DWI 4病灶的csPCa检出率高于DWI 3/DCE+病灶,TB在DWI 3/DCE+患者中诊断性能好。
研究设计与样本
- 回顾性纳入206例接受mpMRI且外周带至少一个PI-RADS 4分病灶的患者,均行MRI/超声融合引导TB和超声引导12针SB。
- 以TB+SB结果为参考标准,比较DWI 4与DWI 3/DCE+的csPCa检出率,并分析TB或SB的敏感度、阴性预测值和诊断准确率。
诊断标准与关键数值
- 使用TB+SB时,DWI 4组csPCa检出率72.22%,DWI 3/DCE+组54.84%,p=0.015。
- 使用SB时,DWI 4组csPCa检出率65.97%,DWI 3/DCE+组46.77%,p=0.010。
- DWI 3/DCE+且PSA 4-10 ng/mL患者,单独TB的阴性预测值最高,95%CI 78.12-100。
临床应用与阅片要点
- 阅片时对外周带PI-RADS 4分病灶应区分DWI 4与DWI 3/DCE+,前者csPCa风险更高。
- 对DWI 3/DCE+且PSA 4-10 ng/mL患者,靶向穿刺阴性预测值高,可辅助决策。
局限性
- 回顾性单中心设计,样本量有限,结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the clinically significant prostate cancer (csPCa) detection rate between diffusion-weighted imaging (DWI) 4 and DWI 3 with positive dynamic contrast-enhanced (DCE) (hereinafter called 'DWI 3/DCE+') lesions in the peripheral zone (PZ) and to explore the diagnostic performance of targeted biopsy (TB) or systematic biopsy (SB) in patients with Prostate Imaging Reporting and Data System (PI-RADS) 4 lesions.
METHODS: We retrospectively enrolled 206 patients who underwent multiparametric magnetic resonance imaging and had at least one PI-RADS 4 lesion in the PZ. All patients subsequently underwent combined magnetic resonance imaging/ultrasound fusion-guided TB and ultrasound-guided 12-core SB. The chi-square test was used to compare the csPCa detection rates between DWI 4 and DWI 3/DCE+ lesions. Based on the TB + SB results as a standard reference, we analyzed the sensitivity, negative predictive value, and diagnostic accuracy of TB alone or SB alone.
RESULTS: Patients with DWI 4 lesions had higher csPCa detection rate than those with DWI 3/DCE+ lesions when using TB + SB, TB, and SB, and the differences were significant for TB + SB (72.22 vs. 54.84%, p = 0.015) or SB (65.97 vs. 46.77%, p = 0.010). For DWI 3/DCE+ patients whose prostate-specific antigen levels ranged from 4 to 10 ng/mL, TB alone showed the highest negative predictive value (95% Cl 78.12-100).
CONCLUSIONS: DWI 4 tends to have worse results than DWI 3/DCE+. TB has great diagnostic performances in DWI 3/DCE+ patients, especially for those prostate-specific antigen ranging from 4 to 10 ng/mL.
引用
- Sun, Wang, Fu, et al. MRI-based analysis of different clinically significant prostate cancer detection rate of prostate imaging reporting and data system score 4 in the peripheral zone. Abdom Radiol (NY). 2022. PMID: 36305943. doi:10.1007/s00261-022-03712-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。